TABLE 7.
Recommended immunization schedule for DTaP and Tdap vaccines in the United States, 2008 to 2014a
| Formulation (reference[s]) | Dosage | Age or other group indication | Special recommendations |
|---|---|---|---|
| DTaP (515, 516) | Five doses for children <7 yr | 2, 4, 6, and 15–18 mo and 4–6 yr | ACIP recommendation |
| Tdap (515) | Single dose | 11–18 yr | Preferred age 11–12 yr; regardless of the timing from the most recent DTaP dose |
| Tdap (670) | Single dose | 19–64 yr | In place of Td booster; in persons who have not previously received Tdap vaccine |
| Tdap (670) | Single dose | ≥65 yr | In place of Td booster; in persons who have not previously received Tdap vaccine |
| Tdap (545, 671) | Single dose during each pregnancy | Pregnancy | Preferred at 27–36 wk of gestation; if the vaccine is not administered during pregnancy, it should be given immediately postpartum |
a
ACIP, Advisory Committee on Immunization Practices; DTaP, diphtheria and tetanus toxoids and acellular pertussis; Td, tetanus and diphtheria toxoids; Tdap, tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis.